Skip to main content
Equibles
GILD logo

GILD · Gilead Sciences, Inc. · Metrics

Track GILD — free

Use GILD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GILD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$145.65 -0.99 (-0.68%) At close · Sep 9
S&P 500 member Nasdaq-100 member Russell 1000 member Rebalance outlook locked
Market Cap
$182.74B
Shares
1.24B

GILD metrics

91 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$145.65
Market cap
$182.74B

Price action

20 metrics
Price change (1W)
-2.2%
Price change (30D)
+10.2%
Price change (3M)
+16.8%
Price change (6M)
-1.3%
Price change (YTD)
+19.5%
Price change (1Y)
+26.5%
Trailing year
Price change (5Y)
+104.0%
52-week high
$155.80
52-week low
$110.56
Change from 52-week high
-5.9%
Change from 52-week low
+32.6%
Annualized volatility
26.8%
Annualized volatility (3M)
30.5%
Beta
0.4
RSI (14D)
56.8
Price vs SMA 50
+7.1%
Price vs SMA 200
+9.1%
Avg volume (3M)
7.03M
Relative volume
0.9
Average dollar volume
$936.09M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
1.24B

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
6.8×
reciprocal yield 14.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
6.0×
reciprocal yield 16.7%
P / book
15.4
reciprocal yield 6.5%
FCF yield
7.1%
TTM · current market cap
Buyback yield
0.8%
P / FCF
14.1
reciprocal yield 7.1%
P / operating cash flow
13.5
reciprocal yield 7.4%
Earnings yield
-1.8%

Historical valuation

8 metrics
P / E historical average (3Y)
147.9×
reciprocal yield 0.7%
P / E historical average (5Y)
96.1×
reciprocal yield 1.0%
EV / revenue historical average (3Y)
5.1×
reciprocal yield 19.5%
EV / revenue historical average (5Y)
4.7×
reciprocal yield 21.3%
EV / EBIT historical average (3Y)
41.8×
reciprocal yield 2.4%
EV / EBIT historical average (5Y)
30.5×
reciprocal yield 3.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
2.2%
Trailing 12 months
Payout ratio
—
Shareholder yield
3.0%
Dividend / share (TTM)
$3.22
Dividend growth YoY
+3.2%
Dividend growth streak
5
Last ex-dividend
2026-06-15

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
78.8%
Operating margin
-8.2%
Trailing 12 months
Net margin
-10.6%
Gross profit (TTM)
$19.78B
Operating profit (TTM)
−$2.50B
Net income (TTM)
−$3.24B
Trailing 12 months
Diluted EPS (TTM)
$-2.66
FCF margin
42.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$18.29

Growth

11 metrics
Revenue growth YoY
+10.2%
Year over year
Net income growth YoY
-635.5%
Revenue (TTM)
$30.46B
Trailing 12 months
EPS growth YoY
-641.7%
Shares change YoY
-1.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+2.6%
Revenue CAGR (5Y)
+3.6%
EPS CAGR (3Y)
+23.0%
EPS CAGR (5Y)
+132.4%
FCF CAGR (3Y)
+4.3%
FCF CAGR (5Y)
+4.7%

Quality

14 metrics
Return on equity
-27.4%
Return on assets
-6.6%
Debt / equity
2.2
Current ratio
1.3
EBITDA (TTM)
—
Free cash flow (TTM)
$12.94B
Quick ratio
1.1
Interest coverage
-2.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$23.07B
Latest balance sheet
Cash & equivalents
$3.18B
Total assets
$49.36B
Total debt
$26.25B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$13.55B
Capital expenditures (TTM)
$609.00M
R&D (TTM)
$6.07B
SG&A (TTM)
$6.52B
Stock compensation (TTM)
$909.00M
R&D / revenue
19.9%
Stock compensation / revenue
3.0%

Ownership (13F)

3 metrics
13F filers
2,289
13F filer change QoQ
-44
Institutional ownership
90.8%

Short interest

3 metrics
Short interest
1.9%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
49 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$15.28M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 882095 CUSIP 375558103 13F (30d) 828 filings 788 filers Visit website Investor relations